IND-KLS  /  Industry hub Ketamine & LSD

Ketamine
& LSD
Marketing .

Marketing for ketamine and psychedelic compound retailers in jurisdictions where legal.

Built for retailers operating in legal jurisdictions only, with a discreet acquisition posture and a customer base that values privacy as a feature.

Get in touch
01 Approach What we bring → what you get
We bring the asset You get the outcome
01
We bring

Direct buys on harm-reduction-adjacent and privacy-focused publications.

You get

Brand presence that respects the customer’s privacy expectation as a feature

02
We bring

Crypto-first checkout (XMR, BTC, USDT) with privacy-respecting flows.

You get

Payment infrastructure aligned with customer privacy expectations

03
We bring

Engagement scope defined within the legal envelope, both jurisdictions.

You get

Operational continuity inside the legal boundary

02 Why other agencies won’t do it 3 reasons mainstream agencies pass
01

Federal scheduling

LSD is Schedule I in most jurisdictions. Ketamine is Schedule III in the US. Most agencies will not engage.

02

No mainstream platforms

No mainstream paid acquisition is available. Acquisition has to be referral and search-driven.

03

Privacy expectations are unusually high

Customers expect agency-level privacy. Most agency infrastructure does not meet the standard.

03 Why you need this Buyer-intent demand in the vertical

The buyer-intent search demand for ketamine & lsd is real, direct, and largely under-served by operators who do not invest in marketing infrastructure. The data below illustrates the categories your customers are already searching for. Ranking, paid placement, and direct-channel presence on these queries are direct revenue.

Buyer-intent keywordMonthly search volume
ketamine therapy40,500/mo
lsd therapy4,400/mo
ketamine treatment cost14,800/mo
04 Our services for ketamine & lsd Each link opens a service-specific page
05 From ketamine & lsd clients Anonymised at client request

Privacy was the differentiator they sold us on, and they delivered it end to end.

Founder / [redacted] / [redacted]

Their insistence on jurisdictional clarity was annoying at first. Two years in, with zero exposure events, I am grateful.

Operations / [redacted] / [redacted]
06 Ketamine & LSD Marketing FAQ The questions ketamine & lsd operators ask first
01 Where do you work in this category?

Only in jurisdictions where the work is legal for the retailer and for us. Most engagement requests in this category we decline at the audit stage.

02 What about ketamine-assisted therapy clinics?

We treat clinics as a separate category — see Psychedelic Therapy. Different regulatory profile, different audience, different marketing playbook.

03 Will you ask about my supply chain?

Only what we need to do the marketing. We do not audit your operations.

04 How do you handle privacy in marketing analytics?

Privacy-respecting analytics with no PII leakage, server-side tagging where possible, and discreet attribution patterns. Customer privacy is a feature for this category, not a compliance afterthought.

05 What channels work for this category?

Direct buys on harm-reduction-adjacent and privacy-focused publications. SEO into research-oriented and community sites. Direct relationships with biohacker creators where the legal envelope allows.

07 Start the conversation Reply within 24h. Mutual NDA on request.

Tell us what you’re working on.

Most engagements start with a three-week audit. The form below tells us enough to scope the call. Or write directly: contacts@despitemarketing.com. Your brief goes straight to a partner, not a triage queue.

Encrypted in transit, read by a partner. We respond within 24 hours, every business day.